Robinswood Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Robinswood Financial’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.3K	Hold	512	–	–	0.01%	250
2026 Q1	$15.4K	Hold	512	–	–	﹤0.01%	251
2025 Q4	$16K	Hold	512	–	–	0.01%	237
2025 Q3	$10.3K	Hold	512	–	–	﹤0.01%	254
2025 Q2	$8.58K	Hold	512	–	–	﹤0.01%	265
2025 Q1	$7.87K	Hold	512	–	–	﹤0.01%	259
2024 Q4	$11.3K	Hold	512	–	–	﹤0.01%	194
2024 Q3	$9.23K	Hold	512	–	–	﹤0.01%	211
2024 Q2	$8.32K	Hold	512	–	–	﹤0.01%	223
2024 Q1	$7.12K	Hold	512	–	–	﹤0.01%	169
2023 Q4	$5.34K	Hold	512	–	–	﹤0.01%	180
2023 Q3	$5.22K	Hold	512	–	–	﹤0.01%	180
2023 Q2	$3.85K	Buy	+512	New	+$4.15K	﹤0.01%	179

Other funds holding TEVA

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Rockingstone Advisors Great Barrington, Massachusetts $249M AUM 31.06% 1-Year Est. Return

Robinswood Financial's TEVA Position: Q2 2026 in Review

Robinswood Financial held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 512 shares worth $17.3K. The position accounts for 0.01% of the portfolio, ranked #250.

Robinswood Financial first reported a position in TEVA in Q2 2023 and has held it in 13 quarters since. 67 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Robinswood Financial held 512 shares of Teva Pharmaceuticals worth $17.3K as of Q2 2026.
Robinswood Financial left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.01% of Robinswood Financial's portfolio in Q2 2026, its #250 holding.
Robinswood Financial first reported a position in Teva Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
67 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.